New England Journal of Medicine Reaches Electronic Distribution Agreement with Reprints Desk Distribution Agreement Expands Reprints Desk's Electronic Sourcing Capabilities to the World's Three Highest 'Impact Factor' Medical Publishers
SANTA MONICA, Calif., Dec. 8, 2010 /PRNewswire/ -- Reprints Desk, Inc. today announced that it has signed a direct agreement with the Massachusetts Medical Society for the electronic distribution of articles from the New England Journal of Medicine. This agreement adds to Reprints Desk's direct distribution agreements covering the top three medical journals in the world – New England Journal of Medicine, Journal of the American Medical Association (JAMA), and The Lancet from Elsevier – based on the Impact Factor. Impact Factors, originally devised by Institute for Scientific Information (ISI) founder Eugene Garfield, are calculated each year for journals indexed in Thomson Reuter's Journal Citation Reports.
"Reprints Desk is honored to be entrusted by NEJM to deliver their valuable content in this manner," said Jan Peterson, Head of Publisher Relations at Reprints Desk. "Reprints Desk is able to provide our global customer base with ultra-rapid document delivery service because of our focus on publisher relationships, which enable us to deliver the majority of our articles within minutes."
The New England Journal of Medicine (NEJM.org) is dedicated to bringing physicians the best research and key information at the intersection of biomedical science and clinical practice, and to presenting the information in an understandable and clinically useful format. Reprints Desk, established in 2006, ranked first overall and in every category in the 2008 Document Delivery Best Practices and Vendor Scorecard by analyst and advisory firm Outsell, Inc., and earned a 97% customer satisfaction rating in Dun & Bradstreet's 2009 Open Ratings survey of existing Reprints Desk customers. Reprints Desk is also a proud corporate sponsor of Room to Read, a non-profit that establishes libraries in developing nations in support of literacy and gender equality in education.
For more information about Reprints Desk and the company's article supply solutions, please visit www.reprintsdesk.com.
The New England Journal of Medicine (NEJM.org) is dedicated to bringing physicians the best research and key information at the intersection of biomedical science and clinical practice, and to presenting the information in an understandable and clinically useful format. A career companion for physicians, NEJM keeps practicing physicians informed on developments that are important to their patients and keeps them connected to both clinical science and the values of being a good physician.
NEJM employs a highly rigorous peer-review and editing process to evaluate manuscripts for scientific accuracy, novelty, and importance. The editors have set policies to ensure that authors disclose all relevant financial associations and that those financial associations do not influence published content. These factors contribute to NEJM's reputation as the "gold standard" for quality biomedical research and for the best practices in clinical medicine.
NEJM is the most widely read, cited, and influential general medical periodical in the world. As it evolves to meet the changing needs of its readers in the 21st century, it is committed to maintaining that reputation and integrity, while using innovative formats and technologies for new features and faster delivery and access.
About Reprints Desk®
Reprints Desk, Inc. helps companies to obtain and use scientific, technical, and medical (STM) literature in compliance with copyright and Good Promotional Practices. Services are designed to save time and money, and improve workflows for professionals in information management, research, regulatory affairs, legal, medical affairs, education, sales and marketing. For more information, visit us online at www.reprintsdesk.com.
Public and Media Relations Contacts:
Ian Palmer, Head of Marketing
Reprints Desk, Inc. | +1 707.658.1931
SOURCE Reprints Desk, Inc.